Buffett Can't Get Enough of This Stock

Berkshire Hathaway buys more of this health care company.

Mar 9, 2014 at 8:00AM

Warren Buffett's Berkshire Hathaway (NYSE:BRK-A) began scooping up shares of DaVita Healthcare Partners (NYSE:DVA), a dialysis provider, back in 2011. The trend continued last week: SEC filings revealed that Berkshire purchased another 1.15 million shares.(NYSE:DVA)

This latest buy brings Berkshire Hathaway's total ownership of DaVita to a hefty 17.7% -- valued around $2.5 billion. That's a lot of treasure. So, why does Buffett love this stock so much?

Warrenbuffett

Source: Wikimedia Commons. 

He loves it, he loves it not
Actually, Buffett didn't buy those shares of DaVita last week for Berkshire Hathaway. Ted Weschler signed the dotted line for the additional stock. Weschler joined Berkshire in late 2011 as a portfolio manager after a successful stint with hedge fund Peninsula Capital Advisors, where he served as managing partner.

So, does this mean Warren Buffett really doesn't love DaVita after all? No -- but the relationship is a little more complicated. 

Buffett doesn't entrust billions of dollars to just anyone. Over the past few years, he carefully screened potential investment managers to bring on board. That process led to the hiring of Weschler and Todd Combs, who had led hedge fund Castle Point Capital from 2005 to 2010. 

In speaking with CNBC, Warren Buffett said that Todd Combs and Ted Weschler "think about investments like I do." That's high praise indeed for an investment manager. So, while Buffett didn't technically buy DaVita shares himself, he provided billions to Ted Weschler to do so, no doubt largely because Weschler looks at many of the same criteria Buffett looks at when deciding which stock to purchase.

Three ways to Ted's heart
What is it about DaVita that appeals to Ted Weschler (and presumably to Warren Buffett as well)? Weschler listed three things he looks for in any health care investment.

First, he wants the company to deliver better quality of care than can be found elsewhere. Fresenius Medical Care (NYSE:FMS) is actually the largest dialysis provider in the world, with 3,200 dialysis centers, compared to DaVita's more than 2,100 centers. However, it's fair to say the two companies are in a league of their own. Together, they command over 70% of the U.S. market.

Second, Weschler thinks any investment in the sector should provide services that lower the total cost of health care. For many patients, the only viable alternative to receiving the dialysis care that DaVita and others provide is to have a kidney transplant, which can run up bills of more than $260,000.

Ted Weschler's third criterion for investing in a health care company actually encompasses three items: higher return on capital, predictable growth, and shareholder-friendly management. DaVita checks off the latter two points, with solid revenue growth and a steady management team.  

Higher return on capital, however, is a different story. DaVita's return on capital has dropped in the last couple of years, to around 4.4%. That's lower than its larger competitor Fresenius. On the other hand, DaVita beat out Berkshire Hathaway for much of the past five years in terms of return on capital. 

DVA Return on Invested Capital (TTM) Chart

DVA Return on Invested Capital (TTM) data by YCharts.

Second that emotion
There are several big factors working in DaVita's favor in the years ahead. Americans are aging, and conditions such as diabetes and high blood pressure, which can ultimately lead to kidney failure, are increasingly prevalent. DaVita's services should be in high demand for a long time to come.

DaVita could also benefit from a new drug potentially on the way to market from its partner, Rockwell Medical (NASDAQ:RMTI). Rockwell believes its Triferic could reduce the need for expensive erythropoiesis-stimulating agent, or ESA, drugs by 35%. With ESAs making up a significant part of DaVita's dialysis expenses, regulatory approval for Triferic should translate to lower costs. Of course, it remains to be seen if Triferic wins that approval.

Since the beginning of 2012, DaVita's shares have gained more than 75%. The company expects 2014 will be more profitable than it initially thought. I think Berkshire has good reason to expand its holdings in DaVita. 

Bring on more Buffett
Warren Buffett has made billions through his investing, and he wants you to be able to invest like him. Through the years, Buffett has offered up investing tips to shareholders of Berkshire Hathaway. Now you can tap into the best of Warren Buffett's wisdom in a new special report from The Motley Fool. Click here now for a free copy of this invaluable report.

Keith Speights has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.


Compare Brokers